Acceptability of A/H1N1 vaccination during pandemic phase of influenza A/H1N1 in Hong Kong: population based cross sectional survey
Identifieur interne : 002C55 ( Main/Exploration ); précédent : 002C54; suivant : 002C56Acceptability of A/H1N1 vaccination during pandemic phase of influenza A/H1N1 in Hong Kong: population based cross sectional survey
Auteurs : Joseph T F. Lau [Hong Kong] ; Nelson C Y. Yeung ; K C Choi ; Mabel Y M. Cheng ; H Y Tsui ; Sian GriffithsSource :
- BMJ [ 0959-8138 ] ; 2009.
English descriptors
- Teeft :
- Administrative region, Census data, Chinese university, Clinical evidence, Clinical trials, Different types, Dosage costs, Family members, Formal education, Free vaccination, General population, Health workers, Healthcare workers, High chance, High risk groups, Hong, Hong kong, Hong kong chinese, Human swine influenza, Hypothetical scenarios, Influenza, Influenza epidemic, Influenza vaccination, Influenza vaccine, Irreversible damage, Kong, Literature review, Outbreak, Pandemic, Participant, Participants variables, Personal cost, Public health, Research table, Respiratory syndrome, Response rate, Sars epidemic, Scientific evidence, Seasonal influenza, Seasonal influenza vaccination, Side effects, Statistics department, Tsui, Universal vaccination, Unsure, Vaccination, Vaccination costs, Vaccine, Vaccine efficacy, World health organization.
Abstract
Objective To investigate the intention of the Hong Kong general population to take up vaccination against influenza A/H1N1. Setting Cross sectional population based anonymous survey. Participants Random sample of 301 adults interviewed by telephone (response rate 80%). Main outcome measure Intention to take up vaccination against influenza A/H1N1 under five hypothetical scenarios: vaccination is free; vaccination per dosage costs less than $HK100 (£8; €9; $13), $HK101-200, or more than $HK200; and no data are available on the efficacy and safety of the vaccine. Results 45% (n=135) of the participants reported that they would be highly likely take up vaccination if it was free. When vaccination incurred a cost, however, the prevalence of uptake decreased: 36% (n=108) would take up vaccination if it cost less than $HK100, 24% (n=72) if it cost $HK101-200, and 15% (n=45) if it cost more than $HK200; and in absence of proved efficacy and safety decreased to 5% (n=14). Moreover, 32% (n=95) considered universal A/H1N1 vaccination unnecessary. Overall, 39% (n=117) of participants believed that A/H1N1 vaccination would prevent the virus being contracted; 63% (n=189) erroneously believed that efficacy of the vaccine had been confirmed by clinical trials, and 16% (n=49) believed that it is necessary for everyone in Hong Kong to take up vaccination against influenza A/H1N1. Conclusions The uptake of vaccination against influenza A/H1N1 by the general population of Hong Kong is unlikely to be high and would be sensitive to personal cost. Evidence about safety and efficacy is critical in determining the prevalence of uptake of vaccination.
Url:
DOI: 10.1136/bmj.b4164
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001005
- to stream Istex, to step Curation: 001005
- to stream Istex, to step Checkpoint: 000C18
- to stream Main, to step Merge: 002D09
- to stream Main, to step Curation: 002C55
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Acceptability of A/H1N1 vaccination during pandemic phase of influenza A/H1N1 in Hong Kong: population based cross sectional survey</title><author><name sortKey="Lau, Joseph T F" sort="Lau, Joseph T F" uniqKey="Lau J" first="Joseph T F" last="Lau">Joseph T F. Lau</name></author><author><name sortKey="Yeung, Nelson C Y" sort="Yeung, Nelson C Y" uniqKey="Yeung N" first="Nelson C Y" last="Yeung">Nelson C Y. Yeung</name></author><author><name sortKey="Choi, K C" sort="Choi, K C" uniqKey="Choi K" first="K C" last="Choi">K C Choi</name></author><author><name sortKey="Cheng, Mabel Y M" sort="Cheng, Mabel Y M" uniqKey="Cheng M" first="Mabel Y M" last="Cheng">Mabel Y M. Cheng</name></author><author><name sortKey="Tsui, H Y" sort="Tsui, H Y" uniqKey="Tsui H" first="H Y" last="Tsui">H Y Tsui</name></author><author><name sortKey="Griffiths, Sian" sort="Griffiths, Sian" uniqKey="Griffiths S" first="Sian" last="Griffiths">Sian Griffiths</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:0DD07808B5EB976F4F7216102DDC627821E80669</idno><date when="2009" year="2009">2009</date><idno type="doi">10.1136/bmj.b4164</idno><idno type="url">https://api.istex.fr/ark:/67375/NVC-DL4F25G9-0/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001005</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001005</idno><idno type="wicri:Area/Istex/Curation">001005</idno><idno type="wicri:Area/Istex/Checkpoint">000C18</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000C18</idno><idno type="wicri:doubleKey">0959-8138:2009:Lau J:acceptability:of:a</idno><idno type="wicri:Area/Main/Merge">002D09</idno><idno type="wicri:Area/Main/Curation">002C55</idno><idno type="wicri:Area/Main/Exploration">002C55</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Acceptability of A/H1N1 vaccination during pandemic phase of influenza A/H1N1 in Hong Kong: population based cross sectional survey</title><author><name sortKey="Lau, Joseph T F" sort="Lau, Joseph T F" uniqKey="Lau J" first="Joseph T F" last="Lau">Joseph T F. Lau</name><affiliation wicri:level="1"><country wicri:rule="url">Hong Kong</country></affiliation></author><author><name sortKey="Yeung, Nelson C Y" sort="Yeung, Nelson C Y" uniqKey="Yeung N" first="Nelson C Y" last="Yeung">Nelson C Y. Yeung</name></author><author><name sortKey="Choi, K C" sort="Choi, K C" uniqKey="Choi K" first="K C" last="Choi">K C Choi</name></author><author><name sortKey="Cheng, Mabel Y M" sort="Cheng, Mabel Y M" uniqKey="Cheng M" first="Mabel Y M" last="Cheng">Mabel Y M. Cheng</name></author><author><name sortKey="Tsui, H Y" sort="Tsui, H Y" uniqKey="Tsui H" first="H Y" last="Tsui">H Y Tsui</name></author><author><name sortKey="Griffiths, Sian" sort="Griffiths, Sian" uniqKey="Griffiths S" first="Sian" last="Griffiths">Sian Griffiths</name></author></analytic><monogr></monogr><series><title level="j">BMJ</title><title level="j" type="abbrev">BMJ</title><idno type="ISSN">0959-8138</idno><idno type="eISSN">1468-5833</idno><imprint><publisher>British Medical Journal Publishing Group</publisher><date type="published" when="2009">2009</date><biblScope unit="volume">339</biblScope></imprint><idno type="ISSN">0959-8138</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0959-8138</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Administrative region</term><term>Census data</term><term>Chinese university</term><term>Clinical evidence</term><term>Clinical trials</term><term>Different types</term><term>Dosage costs</term><term>Family members</term><term>Formal education</term><term>Free vaccination</term><term>General population</term><term>Health workers</term><term>Healthcare workers</term><term>High chance</term><term>High risk groups</term><term>Hong</term><term>Hong kong</term><term>Hong kong chinese</term><term>Human swine influenza</term><term>Hypothetical scenarios</term><term>Influenza</term><term>Influenza epidemic</term><term>Influenza vaccination</term><term>Influenza vaccine</term><term>Irreversible damage</term><term>Kong</term><term>Literature review</term><term>Outbreak</term><term>Pandemic</term><term>Participant</term><term>Participants variables</term><term>Personal cost</term><term>Public health</term><term>Research table</term><term>Respiratory syndrome</term><term>Response rate</term><term>Sars epidemic</term><term>Scientific evidence</term><term>Seasonal influenza</term><term>Seasonal influenza vaccination</term><term>Side effects</term><term>Statistics department</term><term>Tsui</term><term>Universal vaccination</term><term>Unsure</term><term>Vaccination</term><term>Vaccination costs</term><term>Vaccine</term><term>Vaccine efficacy</term><term>World health organization</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract">Objective To investigate the intention of the Hong Kong general population to take up vaccination against influenza A/H1N1. Setting Cross sectional population based anonymous survey. Participants Random sample of 301 adults interviewed by telephone (response rate 80%). Main outcome measure Intention to take up vaccination against influenza A/H1N1 under five hypothetical scenarios: vaccination is free; vaccination per dosage costs less than $HK100 (£8; €9; $13), $HK101-200, or more than $HK200; and no data are available on the efficacy and safety of the vaccine. Results 45% (n=135) of the participants reported that they would be highly likely take up vaccination if it was free. When vaccination incurred a cost, however, the prevalence of uptake decreased: 36% (n=108) would take up vaccination if it cost less than $HK100, 24% (n=72) if it cost $HK101-200, and 15% (n=45) if it cost more than $HK200; and in absence of proved efficacy and safety decreased to 5% (n=14). Moreover, 32% (n=95) considered universal A/H1N1 vaccination unnecessary. Overall, 39% (n=117) of participants believed that A/H1N1 vaccination would prevent the virus being contracted; 63% (n=189) erroneously believed that efficacy of the vaccine had been confirmed by clinical trials, and 16% (n=49) believed that it is necessary for everyone in Hong Kong to take up vaccination against influenza A/H1N1. Conclusions The uptake of vaccination against influenza A/H1N1 by the general population of Hong Kong is unlikely to be high and would be sensitive to personal cost. Evidence about safety and efficacy is critical in determining the prevalence of uptake of vaccination.</div></front></TEI><affiliations><list><country><li>Hong Kong</li></country></list><tree><noCountry><name sortKey="Cheng, Mabel Y M" sort="Cheng, Mabel Y M" uniqKey="Cheng M" first="Mabel Y M" last="Cheng">Mabel Y M. Cheng</name><name sortKey="Choi, K C" sort="Choi, K C" uniqKey="Choi K" first="K C" last="Choi">K C Choi</name><name sortKey="Griffiths, Sian" sort="Griffiths, Sian" uniqKey="Griffiths S" first="Sian" last="Griffiths">Sian Griffiths</name><name sortKey="Tsui, H Y" sort="Tsui, H Y" uniqKey="Tsui H" first="H Y" last="Tsui">H Y Tsui</name><name sortKey="Yeung, Nelson C Y" sort="Yeung, Nelson C Y" uniqKey="Yeung N" first="Nelson C Y" last="Yeung">Nelson C Y. Yeung</name></noCountry><country name="Hong Kong"><noRegion><name sortKey="Lau, Joseph T F" sort="Lau, Joseph T F" uniqKey="Lau J" first="Joseph T F" last="Lau">Joseph T F. Lau</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002C55 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002C55 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:0DD07808B5EB976F4F7216102DDC627821E80669
|texte= Acceptability of A/H1N1 vaccination during pandemic phase of influenza A/H1N1 in Hong Kong: population based cross sectional survey
}}
| This area was generated with Dilib version V0.6.33. |  |